BG60697B2 - Лекарствена форма с продължително освобождаване на база етодолак - Google Patents

Лекарствена форма с продължително освобождаване на база етодолак Download PDF

Info

Publication number
BG60697B2
BG60697B2 BG096617A BG9661792A BG60697B2 BG 60697 B2 BG60697 B2 BG 60697B2 BG 096617 A BG096617 A BG 096617A BG 9661792 A BG9661792 A BG 9661792A BG 60697 B2 BG60697 B2 BG 60697B2
Authority
BG
Bulgaria
Prior art keywords
etodolac
release pharmaceutical
pharmaceutical form
based sustained
hydroxypropylmethylcellulose
Prior art date
Application number
BG096617A
Other languages
English (en)
Inventor
John Michelucci
Deborah SHERMAN
Richard Deneale
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/268,646 external-priority patent/US4966768A/en
Application filed by Wyeth filed Critical Wyeth
Publication of BG60697B2 publication Critical patent/BG60697B2/bg

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Лекарствената форма намира приложение като аналгетично и противовъзпалително средство. Тя представлява таблетка, съдържаща компонентите 1,2-диетил-1,3,4,9-тетрахидропиранол /3,4/ индол-1-оцетна киселина (етодолак), хидроксипропилметилцелулоза, етилцелулоза и освобождаващ агент, например двуосновен натриев фосфат. Хидроксипропилметилцелулозата съдържа хидроксипропил от 7,0 до 8,6% тегл.3 претенции
BG096617A 1988-11-07 1992-07-15 Лекарствена форма с продължително освобождаване на база етодолак BG60697B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/268,646 US4966768A (en) 1987-09-24 1988-11-07 Sustained release etodolac

Publications (1)

Publication Number Publication Date
BG60697B2 true BG60697B2 (bg) 1995-12-29

Family

ID=23023894

Family Applications (1)

Application Number Title Priority Date Filing Date
BG096617A BG60697B2 (bg) 1988-11-07 1992-07-15 Лекарствена форма с продължително освобождаване на база етодолак

Country Status (1)

Country Link
BG (1) BG60697B2 (bg)

Similar Documents

Publication Publication Date Title
DK531088D0 (da) Farmaceutiske praeparater af 1,8-diethyl-1,3,4,9-tetrahydropyrano 3,4-b-indol-1-eddikesyre eller salte deraf
SE8406081D0 (sv) Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
FI883785A0 (fi) Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
MY103212A (en) Zinc-protamine-alpha interferon complex
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
BE899885A (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
NO920785D0 (no) Doseringsform for frigivelse av loeselige eller uloeselige medikamente
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
ES551435A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
NL175882C (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
TW364905B (en) Lactone compound and process of production thereof
PH19471A (en) Oxindole derivatives and pharmaceutical composition containing them
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
MY100780A (en) Azumolene dosage form.
ATE110570T1 (de) Nephroprotektive infusionslösung.
GB1041861A (en) Pyrrolidone derivatives and pharmaceutical preparations containing them
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".